Physician profile
Matthew C Fedor
NPI 1235225624
$5,440.57
in general payments reported to CMS, 2019-2025
23 companies · $80.04 in 2025
The $80.04 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,596 · 2020: $1,019 · 2021: $238 · 2022: $571 · 2023: $432 · 2024: $504 · 2025: $80.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $996 · Travel and Lodging: $19.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $996.16 |
| Travel and Lodging | $19.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,512.82 | 2019-2021 | |
| Boston Scientific Corporation | $768.79 | 2019-2024 | Watchman Flx, Accolade Sr, Watchman Access System |
| Biosense Webster, INC. | $564.55 | 2022-2025 | Nuvision Ice Catheter, Carto 3, Na |
| Medtronic, INC. | $539.82 | 2021-2024 | Pulseselect, Micra |
| Biotronik INC. | $539.42 | 2019-2023 | Selectra, Acticor 7 Vr-T Dx |
| Medtronic Vascular, INC. | $469.90 | 2019-2020 | |
| Amgen INC. | $154.18 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $149.41 | 2019-2023 | Camzyos |
| Pfizer INC. | $123.06 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $109.52 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $89.56 | 2019-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $86.43 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $69.62 | 2019-2020 | |
| Amarin Pharma, INC. | $64.44 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $39.24 | 2019-2024 | Evkeeza |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.40 | 2019 | |
| Alnylam Pharmaceuticals INC. | $27.19 | 2020 | |
| Irhythm Technologies, INC. | $21.67 | 2020 | |
| Elutia, INC. | $21.01 | 2019 | |
| Medtronic USA, INC. | $16.52 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.90 | 2019 | |
| Lundbeck LLC | $13.19 | 2019 | |
| Opsens INC. | $9.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Fedor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.